quantitative polymerase chain reaction (qPCR)-measured telomere length (TL) represents the point of essentially no telomere sequence in a sample. For TL measured using Southern blot (SB), the zero point represents having no telomere and none of the sub-telomeric portions which are also measured by SB. 11 As shown below, these zero points between SB and qPCR measures do not correspond with each other and thereby create highly misleading estimates of measurement error. Further, within the same type of TL measure (SB or qPCR), the zero points often do not correspond across different implementations of these measurement techniques in different laboratories. When these zero points do not correspond, comparisons of CV are invalid.
To illustrate the problem of calculating CVs for data where measures do not correspond in their zero points, consider temperature measured three times with a thermometer which has both degrees Celsius ( C) and degrees Fahrenheit ( F) scales on it (Table 1 , columns 1 and 2).
In this case, for C the CV is 10%, but for F the CV is 3.6%. This is because the zero points of both C and F are arbitrary and do not correspond with each other. As shown below, the same problem of differing zero points is evident in measuring TL. The problem of comparing CVs between qPCR-and SB-measured TL can be shown with an example similar to the temperature illustration above. This can be done by using the results of a previous regression analysis of the same DNA samples measured with qPCR and SB. 12 This regression analysis with SB TL as the dependent variable (Y) and qPCR TL as the independent variable (X) yielded a b estimate of 3.33 kilobase pairs (kbp) and y-intercept of 3.73 kbp. This y-intercept value implies that when qPCR TL is at zero, SB TL would be measured as 3.73 kbp. Similarly large y-intercept values are found in other Using the above b and y-intercept estimates, qPCR measures can be linearly transformed into interpolated SB measures (Table 1 , columns 3 and 4). I note that the specific conversion factor obtained from the particular set of samples and laboratory protocols referenced here should not be used to convert qPCR measures to SB more broadly. [16] [17] [18] By calculating CV values for the qPCR-and SB-interpolated TL measures, the results are values of 6.47% and 2.30%, respectively. Comparisons of the inter-assay CVs of qPCR and SB measures in recent studies show size differences similar to these (6.45% and 1.74%, respectively, in one study 14 and 5.8% and 1.5%, respectively, in another 19 ). Comparisons using conversion factors from other analyses examining qPCR-and SB-measured TL in the same samples yield similar results: a qPCR CV of 6.47% being equivalent to SB CVs of 2.30% and 2.03%. 13, 15 CV statistics have frequently been used to compare the precision of different TL measurement techniques-usually with the suggestion that these show much greater precision for SB than qPCR techniques. Similarly, SB methods using different restriction enzymes result in differing y-intercepts, 11 and variation in subtelomeric length across samples, populations and/or species may also influence the estimated y-intercept value.
Alternatives to assessing TL measurement quality
How can the field of telomere biology better quantify measurement quality? Verhulst and colleagues 2 suggest, using the intra-class correlation coefficient (ICC) instead of the CV. The ICC is not susceptible to the same set of problems pointed out above. However, the ICC quantifies the internal replicability (precision) of measures, but does not tell us about how well each method is measuring the latent construct of telomere length (i.e. accuracy). External validity of TL measures is an approach which should be focused on more to help show measurement accuracy. To accomplish this, I suggest that well-established correlates of TL can be used as markers of external validity. 15 For example, in humans TL is highly heritable and declines with age. Random measurement error attenuates correlations, so if in the same samples putative measures of TL show weaker correlations with family relatedness or with age, than it can be inferred that these measures are likely worse. One possible problem with using heritability as a measure of external validity is that SB measures subtelomeric portions; to the extent that these subtelomeric portions vary by relatedness, this may inflate or deflate TL heritability estimates from SB measures. We are aware of two previous comparisons that have used age as a measure of external validity of qPCR versus SB in the same set of samples. 14, 15 This approach is applied again here using data from the methods paper which debuted the multiplex qPCR assay 12 together with subject age data (both generously shared by Richard Cawthon). These new and past data are found in Table 2 and show little difference in correlations with age between SB and qPCR measures (P ¼ 0.84), suggesting that there is no discernable difference in external validity between these qPCR and SB measures.
Moving forward
The CV is not a valid precision statistic of TL measurements and our above calculations suggest previously observed differences in CV between SB and qPCR may be more representative of improper statistics than actual differences in precision. In the absence of appropriate measures, we cannot say that the precision or accuracy of the qPCR technique is better or worse than SB. The qPCR technique has the clear benefits of requiring far less DNA Fisher's r to Z-transformation was used to combine weighted r-values. and being substantially cheaper than the SB technique. However, the qPCR assay is deceptively difficult to implement, and reasons for concern remain about poor quality uses of the qPCR assay in the literature. For example, the qPCR assay can be substantially influenced by DNA extraction technique and sample handling. [22] [23] [24] [25] [26] A previous cross-population analysis of TL using qPCR (which I was first author of) showed dramatic population variation 27 which probably reflects similar analytical artefacts rather than actual population differences. qPCR techniques do not seem to allow reliable comparison of TL across cohorts or populations unless samples are collected and handled identically. Recent meta-analyses of TL associations tend to reveal high levels of heterogeneity [28] [29] [30] [31] [32] [33] [34] [35] -perhaps due to frequently poor quality of qPCR data.
Abraham Aviv, Simon Verhulst and colleagues 2, 36 have played an important role in stressing that the relative statistical power to detect associations using different TL measurement techniques should be carefully considered. Underpowered studies are more likely to result in false results, to waste resources and to create confusion in the literature. I look forward to seeing power analyses conducted based on valid measurements of precision and accuracy. However, power analyses are not enough. Power analyses should be coupled with cost-benefit analyses that include considerations of financial costs. That is even if SB is shown to be a more precise technique than qPCR, the much higher relative costs of SB may mean that, in cases where many samples are readily available, qPCR is still a more cost-effective technique to glean the same information and level of statistical power. Measurement precision can also be improved by increasing the number of replicates run per sample-something which is much cheaper to do with qPCR than SB. Owing to the complexities of implementation of TL measurement techniques, validation of a technique in one laboratory does not mean that measurements are reliable in another laboratory trying to deploy the technique. I join Abraham Aviv, Simon Verhulst and colleagues in calling for 'impartial and rigorous comparisons in large-scale epidemiological studies between the qPCR and Southern blot methods'. 2, 7 
